Immune oncology in hepatocellular carcinoma-hype and hope

被引：12
作者：
Woerns, Marcus-Alexander [1 ]
Galle, Peter R. [1 ]
机构：
[1] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Internal Med 1, D-55131 Mainz, Germany
来源：
LANCET | 2017年 / 389卷 / 10088期
关键词：
IMMUNOTHERAPY; SORAFENIB; TRIAL; DEATH;
D O I：
10.1016/S0140-6736(17)31044-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2448 / 2449
页数：3
相关论文
共 11 条
[1]   Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial [J].
Bruix, Jordi ;
Qin, Shukui ;
Merle, Philippe ;
Granito, Alessandro ;
Huang, Yi-Hsiang ;
Bodoky, Gyrogy ;
Pracht, Marc ;
Yokosuka, Osamu ;
Rosmorduc, Olivier ;
Breder, Valeriy ;
Gerolami, Rene ;
Masi, Gianluca ;
Ross, Paul J. ;
Song, Tianqiang ;
Bronowicki, Jean-Pierre ;
Ollivier-Hourmand, Isabelle ;
Kudo, Masatoshi ;
Cheng, Ann-Lii ;
Llovet, Josep M. ;
Finn, Richard S. ;
LeBerre, Marie-Aude ;
Baumhauer, Annette ;
Meinhardt, Gerold ;
Han, Guohong .
LANCET, 2017, 389 (10064) :56-66
[2]   Programmed Death Ligand 1 Expression in Hepatocellular Carcinoma: Relationship With Clinical and Pathological Features [J].
Calderaro, Julien ;
Rousseau, Benoit ;
Amaddeo, Giuliana ;
Mercey, Marion ;
Charpy, Cecile ;
Costentin, Charlotte ;
Luciani, Alain ;
Zafrani, Elie-Serge ;
Laurent, Alexis ;
Azoulay, Daniel ;
Lafdil, Fouad ;
Pawlotsky, Jean-Michel .
HEPATOLOGY, 2016, 64 (06) :2038-2046
[3]   Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma [J].
Duffy, Austin G. ;
Ulahannan, Susanna V. ;
Makorova-Rusher, Oxana ;
Rahma, Osama ;
Wedemeyer, Heiner ;
Pratt, Drew ;
Davis, Jeremy L. ;
Hughes, Marybeth S. ;
Heller, Theo ;
ElGindi, Mei ;
Uppala, Ashish ;
Korangy, Firouzeh ;
Kleiner, David E. ;
Figg, William D. ;
Venzon, David ;
Steinberg, Seth M. ;
Venkatesan, Aradhana M. ;
Krishnasamy, Venkatesh ;
Abi-Jaoudeh, Nadine ;
Levy, Elliot ;
Wood, Brad J. ;
Greten, Tim F. .
JOURNAL OF HEPATOLOGY, 2017, 66 (03) :545-551
[4]  
El-Khouiery AB, 2017, LANCET
[5]   Sorafenib in advanced hepatocellular carcinoma [J].
Llovet, Josep M. ;
Ricci, Sergio ;
Mazzaferro, Vincenzo ;
Hilgard, Philip ;
Gane, Edward ;
Blanc, Jean-Frederic ;
Cosme de Oliveira, Andre ;
Santoro, Armando ;
Raoul, Jean-Luc ;
Forner, Alejandro ;
Schwartz, Myron ;
Porta, Camillo ;
Zeuzem, Stefan ;
Bolondi, Luigi ;
Greten, Tim F. ;
Galle, Peter R. ;
Seitz, Jean-Francois ;
Borbath, Ivan ;
Haussinger, Dieter ;
Giannaris, Tom ;
Shan, Minghua ;
Moscovici, Marius ;
Voliotis, Dimitris ;
Bruix, Jordi .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (04) :378-390
[6]   Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study [J].
Park, Joong-Won ;
Chen, Minshan ;
Colombo, Massimo ;
Roberts, Lewis R. ;
Schwartz, Myron ;
Chen, Pei-Jer ;
Kudo, Masatoshi ;
Johnson, Philip ;
Wagner, Samuel ;
Orsini, Lucinda S. ;
Sherman, Morris .
LIVER INTERNATIONAL, 2015, 35 (09) :2155-2166
[7]   Immunological landscape and immunotherapy of hepatocellular carcinoma [J].
Prieto, Jesus ;
Melero, Ignacio ;
Sangro, Bruno .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2015, 12 (12) :681-700
[8]   A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C [J].
Sangro, Bruno ;
Gomez-Martin, Carlos ;
de la Mata, Manuel ;
Inarrairaegui, Mercedes ;
Garralda, Elena ;
Barrera, Pilar ;
Ignacio Riezu-Boj, Jose ;
Larrea, Esther ;
Alfaro, Carlos ;
Sarobe, Pablo ;
Jose Lasarte, Juan ;
Perez-Gracia, Jose L. ;
Melero, Ignacio ;
Prieto, Jesus .
JOURNAL OF HEPATOLOGY, 2013, 59 (01) :81-88
[9]   Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma patients after curative resection, a systematic review and meta-analysis [J].
Wang, Haiqing ;
Liu, Aixiang ;
Bo, Wentao ;
Feng, Xielin ;
Hu, Yong ;
Tian, Lang ;
Zhang, Hui ;
Tang, Xiaoli .
DIGESTIVE AND LIVER DISEASE, 2016, 48 (11) :1275-1282
[10]   HCC therapies-lessons learned [J].
Woerns, Marcus-Alexander ;
Galle, Peter Robert .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2014, 11 (07) :447-452
12